Periarticular Injection Versus Femoral Nerve Block for Pain Relief After Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial.

Kenji Kurosaka, Sachiyuki Tsukada, Hiroshi Nakayama, Tomoya Iseki, Ryo Kanto, Ryo Sugama, Shinichi Yoshiya

Journal: Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 2019;34(1):182-188

PMID: 29203380

Abstract

PURPOSE

To compare the effectiveness and safety of periarticular injection (PI) with those of femoral nerve block (FNB) after anterior cruciate ligament (ACL) reconstruction.

METHODS

A total of 129 patients scheduled for ACL reconstruction were randomly assigned to receive PI or FNB. Other perioperative interventions were identical for all patients. The primary outcome was the postoperative pain score 24 hours after surgery, which was measured using a 100-mm visual analog scale (VAS). The pain scores were also assessed to determine whether the VAS score would reach the threshold values reported for the minimal clinically important difference (MCID) and patient acceptable symptomatic state (PASS).

RESULTS

The PI group had significantly lower VAS scores 24 hours after ACL reconstruction than the FNB group (21 mm vs 39 mm; P < .0001). Consequently, the primary outcome reached the level of clinical significance as indicated by the threshold values of an MCID of 9.9 and a PASS of 33. The PI group also had a significantly lower VAS score at rest at 4 hours, 8 hours, and 2 days after surgery (30 mm vs 39 mm [P = .025], 25 mm vs 33 mm [P = .022], and 22 mm vs 32 mm [P = .0022], respectively). The opioid consumption during the initial 24 hours was significantly lower in the PI group (354 μg vs 503 μg; P = .0003). The complication rate, including opioid-related complications, was not significantly different between groups.

CONCLUSION

The patients treated with PI had significantly better pain scores and lower opioid consumption than those treated with FNB without elevating the complication rate.

LEVEL OF EVIDENCE

Level I, randomized controlled trial.

Copyright © 2017 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Address: Department of Orthopaedic Surgery, Hyogo College of Medicine, Nishinomiya City, Hyogo, Japan. Electronic address: [email protected].; Department of Orthopaedic Surgery, Hokusuikai Kinen Hospital, Mito City, Ibaraki, Japan.; Department of Orthopaedic Surgery, Hyogo College of Medicine, Nishinomiya City, Hyogo, Japan.; Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka City, Osaka, Japan.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.